Figure 1 TRIB3 expression is associated with poor prognosis in breast cancer. Patients where divided into three groups based on their TRIB3 mRNA levels; less than 33% (dotted line), 33% to 66% (dashed line) and more than 66% (solid line). Kaplan-Meier plots of (a) disease-free survival (DFS; P = 0.002) and (b) overall survival (OS; P < 0.001) in breast cancer patients (n = 274) and DFS (c) in patients with mastectomy without further radiotherapy (n = 67, P = 0.719) and (d) in patients that received postoperative radiotherapy (n = 179, P = 0.005).